发明名称 Optically pure camptothecin analogues
摘要 <p>Two optically pure beta-hydroxy lactone camptothecin analogs (+)-5-ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H-oxepino(3',4':6,7)indolizino(1,2-b)quinoline-3,15-dione (I) and (+)-9-chloro-5-ethyl-5-hydroxy-10-methyl-12-(4-methylpiperidinomethyl)-4,5,13,15-tetrahydro-1H,3H-oxepino(3',4':6,7)indolizino(1,2-c)quinoline-2,15-dione (II), as well as one of its salts, (+)-1-(9-chloro-5-ethyl-5-hydroxy-10-methyl-3,15-dioxo-4,5,13,15-tetrahydro-1H,3H-oxepino(3',4':6,7)indolizino(1,2-b)quinoline-12-yl methyl)-4-methyl-hexahydropyridinium chloride (III) and intermediates (M) are new. Optically pure beta-hydroxy lactone camptothecin analogs of formulae (I) and (II), as well as salts of (II) of formulae (III) are new. Independent claims are also included for industrial intermediates of formula (M) and their preparation. R = 1-10C alkyl, especially ethyl.</p>
申请公布号 EP1378512(A1) 申请公布日期 2004.01.07
申请号 EP20030077049 申请日期 1998.08.07
申请人 SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES ( S.C.R.A.S.) 发明人 CAZAUX, JEAN-BERNARD;LAVERGNE, OLIVIER;LE BRETON, CHRISTINE;MANGINOT, ERIC;BIGG, DENNIS
分类号 C07D491/22;A61K31/435;A61K31/4353;A61K31/4375;A61P31/12;A61P33/00;A61P35/00;C07D491/04;C07D491/044;(IPC1-7):C07D491/04 主分类号 C07D491/22
代理机构 代理人
主权项
地址